Acacia research corp (ACTG)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues

11,246

131,506

65,402

-

-

-

-

-

-

-

-

Revenues

-

-

-

152,699

125,037

130,876

130,556

250,727

172,256

131,829

67,340

Portfolio operations:
Inventor royalties

4,944

35,168

4,952

22,730

18,462

20,670

29,724

26,028

43,727

25,292

15,673

Contingent legal fees

591

31,501

16,682

26,474

16,169

23,563

24,784

24,651

40,281

19,906

15,945

Patent acquisition expenses

0

4,000

-

-

-

-

-

-

-

-

-

Patent acquisition expenses

-

-

0

-

-

-

-

-

-

-

-

Litigation and licensing expenses - patents

7,803

8,866

18,219

27,858

39,373

37,614

39,335

21,591

13,005

13,891

14,055

Amortization of patents

3,194

27,120

22,154

34,208

53,067

53,745

49,039

39,019

9,745

6,931

4,634

Impairment of Goodwill

-

-

-

0

30,149

0

0

-

-

-

-

Other portfolio expenses

1,756

2,602

1,200

500

4,141

1,548

3,506

0

0

-

-

Total portfolio expenses

18,288

109,257

-

-

-

-

-

-

-

-

-

Net portfolio income (loss)

-7,042

22,249

-

-

-

-

-

-

-

-

-

Verdict insurance proceeds

-

-

-

-

-

-

-

-

12,451

0

0

Verdict insurance proceeds related costs

-

-

-

-

-

-

-

-

7,661

0

0

General and administrative expenses

16,376

18,728

27,219

32,919

38,176

48,554

59,229

54,083

35,693

25,067

21,070

Research, consulting and other expenses - business development

-

-

-

3,079

3,391

3,840

3,251

4,943

4,338

2,121

1,689

Impairment of patent-related intangible assets

0

28,210

2,248

42,340

74,731

3,497

4,619

-

-

-

-

Total Portfolio Operations

-

-

65,455

-

-

-

-

-

-

-

-

Net portfolio income (loss)

-7,042

22,249

-53

-

-

-

-

-

-

-

-

Total operating costs and expenses

-

-

-

190,108

277,659

193,031

213,487

170,315

141,999

93,208

73,066

Operating loss

-23,418

-24,689

-27,272

-37,409

-152,622

-62,155

-82,931

80,412

30,257

38,621

-5,726

Other income (expense):
Gain on Conversion of Loan and Accrued Interest

-

-

2,671

0

0

-

-

-

-

-

-

Gain on exercise of Primary Warrant

-

-

4,616

0

0

-

-

-

-

-

-

Change in fair value of investment, net (Note 5)

9,899

-59,103

-

-

-

-

-

-

-

-

-

Loss on sale of investment (Note 5)

9,230

19,095

-

-

-

-

-

-

-

-

-

Impairment of other investment (Note 6)

8,195

1,000

-

-

-

-

-

-

-

-

-

Gain on disposal of other investment (Note 6)

2,000

0

-

-

-

-

-

-

-

-

-

Change in fair value of the Series A and B warrants and embedded derivative

4,518

0

-

-

-

-

-

-

-

-

-

Change in fair value of investment

-

-

42,239

0

0

-

-

-

-

-

-

Income (Loss) from Equity Method Investments

-

-

-220

0

0

-

-

-

-

-

-

Other Income

-

-

-

0

0

-

-

500

0

0

-

Investment Income, Interest

-

-

-

798

-56

-

-

482

81

103

-

Interest income and other

-

-

1,605

-

-

-

-

-

-

-

-

Write off of investment

-

-

-

-

-

-

-

45

0

0

-

Interest income and other

-

-

1,000

798

-56

-595

2,131

937

96

135

-

Interest income and other

5,473

218

51,911

-

-

-

-

-

-

-

-

Net realized gain (loss) on investments

-

-

-

-

-

-

-

-

15

32

-

Total other income (expense)

4,465

-78,980

-

-

-

-

-

-

-

-

-

Interest and investment income

-

-

-

-

-

-

-

-

-

-

302

Loss before income taxes

-18,953

-103,669

24,639

-36,611

-152,678

-62,750

-80,800

81,349

30,353

38,756

-5,424

Income tax benefit (expense)

-1,824

1,179

2,955

18,188

4,800

3,912

-21,958

22,060

8,708

1,740

209

Net loss including noncontrolling interests in subsidiaries

-17,129

-104,848

-

-

-

-

-

-

-

-

-

Business Acquisition, Pro Forma Provision for Income Taxes

-1,824

1,179

2,955

18,188

4,800

-

-

-

-

-

209

Net loss including noncontrolling interests in subsidiaries

-

-

21,684

-54,799

-157,478

-66,662

-58,842

59,289

21,645

37,016

-5,633

Net (income) loss attributable to noncontrolling interests in subsidiaries

-14

181

-496

-732

2,558

-633

-2,408

-164

539

2,965

5,657

Business Acquisition, Pro Forma Net (Income) Loss Attributable to Noncontrolling Interests

-14

181

-496

-732

2,558

-

-

-

-

-

5,657

Net loss attributable to Acacia Research Corporation

-17,115

-105,029

22,180

-54,067

-160,036

-66,029

-56,434

59,453

21,106

34,051

-11,290

Less: Accretion of Series A redeemable convertible preferred stock

307

0

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders - basic and diluted

-17,422

-105,029

22,147

-54,067

-160,730

-66,755

-56,945

57,564

20,265

-

-

Basic net loss per share of common stock

-0.35

-2.10

-

-

-

-

-

1.22

0.51

1.05

-0.38

Weighted average number of shares outstanding - basic

49,764

49,969

50,495

50,075

49,505

-

-

47,251

39,743

32,306

29,914

Less: Accretion of redeemable preferred stock

307

0

-

-

-

-

-

-

-

-

-

Less: Mark-to-market adjustment for preferred stock embedded derivative

-3,258

0

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-

-

0.44

-1.08

-3.25

-1.37

-1.18

-

-

-

-

Net loss attributable to common stockholders - diluted

-20,373

-105,029

-

-

-

-

-

57,577

20,273

-

-

Diluted net loss per share of common stock

-0.40

-2.10

-

-

-

-

-

1.21

0.50

0.97

-0.38

Weighted average number of shares outstanding - diluted

50,896

49,969

50,692

50,075

49,505

-

-

47,584

40,150

35,081

29,914

Common Stock, Dividends, Per Share, Cash Paid

-

-

-

0.00

0.50

0.50

0.37

0.00

0.00

-

-

Weighted average number of shares outstanding - basic and diluted

-

-

-

-

-

48,658

48,155

-

-

-

-

General and administrative expenses(1)

16,376

18,728

-

-

-

-

-

-

-

-

-

Common Stock [Member]
Change in fair value of investment

-

-

33,922

-

-

-

-

-

-

-

-

Realized Investment Gains (Losses)

-

-

0

-

-

-

-

-

-

-

-